Eleven organizations representing health care providers, including the AHA, April 29 urged the Centers for Medicare & Medicaid Services not to hold accountable care organizations responsible for anomalous Medicare spending beyond their control, such as aberrant catheter spending, noting significantly higher spending in 2023 for two catheter codes billed by durable medical equipment suppliers. The Institute for Accountable Care analyzed Medicare claims for those codes from the CMS Virtual Research Data Center and discovered a nearly 20-fold increase over two years — from $153 million in 2021 to $3.1 billion in 2023 — with almost all of the increase attributed to just 10 DME suppliers. The group asks CMS to remove questionable claims from ACO financial calculations, create an outlier policy to account for other forms of anomalous spending, and provide ACOs an option for a second reconciliation.  
  
"We strongly urge CMS to address these policies for the Medicare Shared Savings Program (MSSP), in the upcoming Medicare Physician Fee Schedule proposed rule, and the ACO Realizing Equity, Access, and Community Health (REACH) Model, which doesn’t need formal rulemaking," the letter notes. "We also request that CMS continue to work with stakeholders on long-term solutions to address suspected and confirmed fraud." 

Related News Articles

Headline
The AHA July 11 released its quarterly Health Care Plan Accountability Update, a roundup of news, letters, statements and other resources covering private…
Headline
The AHA submitted a statement July 11 for a Senate Special Committee on Aging hearing on health care transparency and lowering health care costs. The AHA…
Headline
The Centers for Medicare & Medicaid Services July 10 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The Healthcare Equality Network July 3 sent a letter to the Centers for Medicare & Medicaid Services, expressing concerns about claims denials by…
Headline
The Department of Health and Human Services’ Office of Inspector General last week announced its intent to investigate Medicare Advantage Organizations’ prior…
Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…